GameChangers: Coronary Artery Disease Guideline Update

GameChangers: Coronary Artery Disease Guideline Update

The American Heart Association updated the Coronary Artery Disease (CAD) guidelines for the first time in a decade. Join host, Geoff Wall, as he evaluates what’s new in CAD pharmacotherapy.

THE GAMECHANGER: CAD pharmacotherapy is dependent on aggressive lipid management whereas antiplatelet and beta-blocker therapy is now more nuanced.

Upon successful completion of this course, learners should be able to:
1. Discuss the new AHA coronary artery disease (CAD) guidelines
2. Apply AHA CAD guidelines for medical management of a patient with stable CAD

Geoffrey C. Wall, PharmD, FCCP, BCPS, CG
Professor of Clinical Sciences
Drake University College of Pharmacy and Health Sciences

Dr. Wall is a member of the Janssen Speaker’s Bureau. All relevant financial relationships have been mitigated.  

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Release Date: September 4, 2023
Planned Expiration Date: September 4, 2024

Copyright 2023, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.  

Universal Activity Number (UAN): 0107-0000-23-295-H01-P
Application-based CPE Activity

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Additional information


0h 30m

Topic Designator

Disease State/Drug Therapy



ACPE Topic




Release Date






ACPE Number


This course is in our subscription.